I am still here .. I bought a large position of Gbim when it was in mid 70 cente
We now own 1/3 of old Biod pipeline ..2/3 goes to ALBO old shareholders .. Also our cash is gong to be used to fund ALBO dev .. They should have sold pipeline instead of RM
Sellers are giving zero possibility that phase 3 data for 12 to 13 sites were switched placebo with drug
I don't see this as a small possibility .. How could drug produce positive effects as compared to placebo for ALL 100 patients in phase 2b for all 11 questions and do same for 38 sites and then 12 sites do the exact opposite ??
If data were switched for those 11 sites, they have met p3 and thsi should go to $20